Medical Drugs Product Applications For The Medical / Health Care Industry

The new standard for quality, capacity, and speed. Deliver the best cell lines. Set your IND up for success by getting FDA-accepted monoclonality assurance in just ...

By Bruker Corporation based in Billerica, MASSACHUSETTS (USA).

The Body’s Built In Pain And Inflammation Defense System. There are a number of pain defense systems that operate in our body. One of them is called the Endocannabinoid System or ECS for short. The ECS is a part of the body’s built in pain and inflammation defense system and there are a number of receptors that make up this system. The two major types of receptors in the ECS are called CB1 and CB2 ...

By Tetra Bio-Pharma based in Orleans,, ONTARIO (CANADA).

Thermal Management: Pyroid HT pyrolytic graphite thermal spreaders and thermal vias are a powerful new material solution in the battle against thermal heat in state-of-the-art electronic circuits and devices. HT material matches the heat spreading capability of CVD diamond at 1700 W/mK but at substantially better economics. ...

By CETCO based in New York, NEW YORK (USA).

Health Canada recently released “Proposed Regulations Amending the Cannabis Regulations (new classes of cannabis) and Proposed Order Amending Schedules 3 and 4 to the Cannabis Act”. These proposed changes introduce three new classes of cannabis products: edibles, concentrates and topicals. The introduction of these new classes may present an opportunity for the Company to bring combination products to the market as an adult-use edible cannabis product. It is proposed that only approved food ingredients ...

By CanaQuest Medical Corp. based in Mississauga, ONTARIO (CANADA).

Deliver the right cells to the patient on time. Maximize Functional Characterization of Your Precious T Cell Samples. The Opto™ Cell Therapy Development workflow accelerates the creation of better therapeutics by performing multiple functional assays across 1,000s of individual T cells in a matter of days. Deeply characterize, profile, and map your T cell populations at the single-cell level to directly link phenotype to gene ...

By Bruker Corporation based in Billerica, MASSACHUSETTS (USA).

In modern medicine there is a constant demand to collect data about patients’ physical, physiological and behavior, monitor medical instruments inside hospitals to reduce multiple systems or shortage, monitor hospital staff’s hygiene with a dedicated bracelet and many other applications that requires monitoring and data ...

By Sol Chip Ltd. based in Haifa, ISRAEL.

2A Pharma’s vaccine platform is based on mutated parvoviral particles consisting essentially of one protein. The particles contain no viral genome and are replicative defective and non-pathogenic. The particle capsid surface has repetitive, immunogenic sites, where peptides of interest can be inserted and allows us to generate monovalent or bivalent vaccines as required. Each peptide of interest will be presented 60 times on the capsid surface and both the innate and adaptive immune systems are activated to ...

By 2A Pharma ApS based in Aalborg Øst, DENMARK.

Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...

By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).

High Performance Across the Breadth of Biotech. The NX One is a perfect fit for a wide variety of sectors and application areas spanning fundamental biological research to industrial and clinical workflows. Access your cells faster and at a fraction of the ...

By Nodexus Inc. based in Hayward, CALIFORNIA (USA).

Early Ambulation. Simple. Proven: VASCADE MVP enables Early Ambulation, is simple to use and proven, providing femoral venous closure in patients who have undergone catheter-based interventions using procedure sheaths with an Inner Diameter of 6 to 12 French. ...

By Cardival Medical, Inc. based in Santa Clara, CALIFORNIA (USA).

Explore interaction profiles and identify off-target binding. Most drugs in common use are small organic molecules which interact functionally with proteins, either acting as ligands for receptors, inhibiting enzymes or blocking protein interactions, etc. Their activities have generally been established by specific cellular and molecular assays to determine mode of action. While frequently well tolerated, side-effects are nevertheless commonplace and can be the result of unexpected interference with unintended ...

By Cambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM.

Pharmacogenomics is the study of genetic variations that influence an individual’s response to medications. Each person responds uniquely to treatment so the same approach may not be effective or may cause adverse side effects in other patients. Understanding this information is helpful to physicians in developing a strategy to optimize drug therapies. Data concerning a patient’s genotype are used to maximize drug efficacy while minimizing adverse drug effects and drug-drug interactions. ...

By Tesis Biosciences based in Scottsdale, ARIZONA (USA).

CROs can differentiate their services to sponsors with the white-labeled Jeeva eClinical technology platform advantage. Maximize the probability of winning contracts with sponsors by differentiating your proposals with Jeeva eClinical cloud. Sponsors want to know how you can ensure faster patient recruitment and better retention compared to your peers. Jeeva can rapidly turnaround with a budget proposal and branded material for inclusion in your response to sponsor RFPs and support you throughout the ...

By Jeeva Informatics Solutions Inc. based in Manassas, VIRGINIA (USA).

From accelerating drug discovery to leveraging real world evidence, Centaur Labs provides life sciences innovators with high-quality medical data annotations at unprecedented speed and ...

By Centaur Labs based in Boston, MASSACHUSETTS (USA).

Maximize the probability of your clinical trial success by accelerating patient enrollment and flexible operations. Whether it is investigator-initiated study, observational study, phase 0, 1, 2, 3, or 4 post-market trials, real-world evidence generation to supplement your randomized controlled clinical trial, maximizing the speed of patient enrollment is the proven way to minimize your ...

By Jeeva Informatics Solutions Inc. based in Manassas, VIRGINIA (USA).

Generating cell lines has often been inefficient and affected by inaccurate limited dilution methods or the shear stress caused by conventional flow cytometer and traditional high-pressure cell sorters. NanoCellect Biomedical provides cell sorting solutions that allow to sort cells and establish stable cell lines using gentle low-pressure microfluidics. The WOLF’s ability to protect cell viability after sorting makes it an integral part of any cell line development workflow such as: Recombinant protein ...

By NanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA).

More than 5 million people in the United States and an estimated 50 million people worldwide are living with Alzheimer’s disease. More than 10 million people worldwide are living with Parkinson’s. Brain tumors and tumors of the central nervous system are the most common form of cancer in children under 19 and the leading cause of cancer-related deaths in children under 14 in the U.S. While antibody drugs have made great strides in cancer therapies, crossing the blood-brain barrier (BBB) and ...

By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).

The first product candidate to utilize the Discogenic Cell platform is IDCT ...

By DiscGenics, Inc. based in Salt Lake City, UTAH (USA).

Prescriptive Use To Mitigate Radiotherapy Damage To Normal Tissue and Allow More Effective Cancer Therapy. Almost 70% of all patients with cancer receive radiotherapy alone or in combination with surgery or chemotherapy. The amount of radiation that can be used to control tumor growth, however, is limited by normal tissue damage. Development of drugs to selectively reduce radiotherapy-induced normal tissue damage may improve post-therapy quality of life and allow more aggressive radiotherapy protocols to better ...

By Chrysalis BioTherapeutics, Inc. based in Galveston, TEXAS (USA).

Cancer is one of the leading causes of deaths in India and a major public health concern. It is estimated that there are around 1 million new cancer cases every year and as many as 5 lakh deaths occur annually. Around 71% of all cancer deaths in India occur in people 30 to 69 years of age, when adults are very productive. The burden of cancer is expected to further increase due to increase in life expectancy, heavy use of tobacco and other risk factors such as radiation, viruses, ...

By inDNA Research Labs based in , INDIA.